Learn, Analyse & Invest
only with
only with
+91
Download Orca
Glenmark Pharmaceuticals Ltd.
Glenmark Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Mid-cap - With a market cap of ₹575.13 Cr.
Financial Strength
Stable
Ratios Analysis
Balance Sheet
Results Analysis
Cash Flow
Profit Loss
Key Metrics
Market Capitalisation
₹ 57512.53 Cr.
Enterprise Value
₹ 57785 Cr.
Shares Outstanding
28.22 Cr.
Dividend Yield
0.12%
Face Value
₹ 1
Book Value
₹ 858.31
TTM EPS
0.74 Cr.
TTM-PE
2756.68
Latest Equity
28.22
Latest Reserve
₹ 24193
Peers Comparison
| Stocks | CMP (₹) | Mark. Cap Size | P/E | P/B | EPS | ROE |
|---|---|---|---|---|---|---|
| Ipca Laboratories | Loading... | Mid-cap | 51.63 | 5.48 | 29.08 | 11.86 |
| Ajanta Pharma | Loading... | Mid-cap | 35.53 | 8.64 | 73.69 | 25.06 |
| Glaxosmithkline Phar | Loading... | Mid-cap | 52.55 | 24.79 | 54.76 | 49.43 |
| Pfizer | Loading... | Small-cap | 23.86 | 4.34 | 167.78 | 19.65 |
| Abbott India | Loading... | Mid-cap | 46.17 | 15.53 | 665.62 | 35.98 |
